FL-VIRGIN-VOYAGES
Virgin Voyages, the new lifestyle brand set to disrupt the travel industry, today announced its exclusive on-demand champagne delivery service, Shake for Champagne™ . Continuing to create the most irresistible experiences at sea, Virgin Voyages is enabling Sailors to request champagne, anywhere on board Scarlet Lady, with a simple shake of their phone.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191009005133/en/
Those looking to take indulgence to the next level can also treat themselves in the newly revealed luxurious champagne lounge and caviar bar, Sip .
“It is never too early for champagne and there is always something to toast to while aboard Scarlet Lady. We want our Sailors to enjoy a glamorous holiday and what better way to feel like a RockStar than a sip of bubbly whenever and wherever you want it,” said Tom Mcalpin, president and CEO of Virgin Voyages.
SHAKE FOR CHAMPAGNE™
Virgin Voyages is giving its Sailors one more reason to celebrate all of life’s moments with its on-demand delivery service, Shake for Champagne™. When the Virgin Voyages Sailor App is shaken, a secret Virgin Voyages Champagne button is revealed and, with just one press, a bottle of Möet & Chandon Impérial will be delivered to the Sailor.
“There’s nothing more luxurious than having champagne at your beck and call or even a shake. We are committed to creating the world’s most irresistible travel brand, so we thought long and hard about how to help our Sailors effortlessly get a sip of bubbly during their voyage, and presto Shake for Champagne™ was conjured up!” said Nathan Rosenberg, CMO for Virgin Voyages.
Delivered in an eye-catching, gleaming Virgin red champagne bucket, which is sure to make everyone around envious, the service includes a 750ml bottle of Möet & Chandon Impérial with two glasses. Möet & Chandon Impérial is a blend of over 200 crus, mingling the full body of pinot noir with the suppleness of Meunier and the finesse of chardonnay – the perfect pairing for a day or evening sailing in the warm Caribbean sea.
SIP
Sip is a decadent lounge designed to be enjoyed with a chilled glass of bubbles. Featuring a diverse curation of champagne labels, including Moët & Chandon – Virgin Voyages’ featured champagne house. Sailors can opt for a glass of bubbles priced from $9 or splash out on a $1,000 vintage bottle. In a nod to Virgin’s quintessential British heritage and eccentricity, Sip will offer a signature afternoon high tea, which will delight the eyes as well as the taste buds, while celebrating oceanic elements.
Designed by the Virgin Voyages design team, with spatial design by HKS Hospitality Interiors, the lounge was inspired by the glamour and effervescence of champagne. Featuring a long marble bar with rose-gold inlay, Sip encourages Sailors to indulge in one of the most luxurious pairings of them all, champagne and caviar. Gold and rose-pink hues echo the color of the champagnes that will be served, and are beautifully offset by deep watery blues and carrara white marble bars and tables. The deep ocean blue banquette wall and carpet that wraps through the space, will create a chance to revel or relax at all times of day as the ship sails through the ocean’s blue waves.
LIMITED-TIME BOOKING OFFER
Sailors can toast to Virgin Voyages’ inaugural season now through November 30, as those who book April or May sailings will receive a complimentary special Virgin Voyages limited-edition bottle of Möet & Chandon Impérial in their cabin upon their arrival. In addition, Sailors who book now can snag their voyage with half off their deposit. Future Sailors and First Mates are invited to check out Virgin Voyages by visiting www.virginvoyages.com .
ABOUT VIRGIN VOYAGES
Virgin Voyages is a global lifestyle brand committed to creating the world’s most irresistible holiday. With operations in the US, UK, and Europe, Virgin Voyages currently has four ships on order with master shipbuilder Fincantieri.
With its inaugural season scheduled for 2020, Virgin Voyages’ first ship Scarlet Lady was designed to reflect a yacht’s sleek luxury. Featuring spaces designed by some of the top names in contemporary design, Scarlet Lady will be Adult-by-Design, a sanctuary at sea for the 18+ traveler.
A dose of ‘Vitamin Sea’ will be naturally intertwined across the entire ship, with well-being activated through a mix of high-energy moments coupled with relaxation and rejuvenation. The Scarlet Lady will also feature alluring entertainment and 20+ world-class intimate eateries on board. Putting a twist on luxury, which the company refers to as Rebellious Luxe, Virgin Voyages will offer incredible value for its Sailors with all restaurants, group fitness classes, soft drinks, gratuities, WiFi and many more Virgin surprises included within the voyage fare.
Scarlet Lady will sail from Miami to the Caribbean in 2020, hosting more than 2,770 sailors and 1,150 amazing crew from around the world. Keep watch on virginvoyages.com for more updates.
Follow Virgin Voyages:
Instagram: @virginvoyages
Facebook: @virginvoyages
Twitter: @virginvoyages
LinkedIn: Virgin Voyages
YouTube: Virgin Voyages
View source version on businesswire.com: https://www.businesswire.com/news/home/20191009005133/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom